Disulfiram metabolite Cu(DDC)<sub>2</sub> enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistance
Christopher J. McCabe(University Hospitals Birmingham NHS Foundation Trust)
University of Birmingham Research Portal (University of Birmingham)
January 26, 2026
Cited by 0
Related Papers
Manipulation of PBF/PTTG1IP Phosphorylation Status; a Potential New Therapeutic Strategy for Improving Radioiodine Uptake in Thyroid and Other Tumors
|The Journal of Clinical Endocrinology & Metabolism|2013|48
Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment
|Cancer Research|2011|48
PTTG-Binding Factor (PBF) Is a Novel Regulator of the Thyroid Hormone Transporter MCT8
|Endocrinology|2012|24
Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF
|Endocrine Related Cancer|2017|10
Dual agonism of sodium iodide symporter function <i>in vivo</i>
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0